Masanori Fujii

Phase II Trial of Gefitinib in Combination with Bevacizumab as First-Line Therapy for Advanced Non–Small Cell Lung Cancer with Activating EGFR Gene Mutations: The Okayama Lung Cancer Study Group Trial 1001

Eiki Ichihara, Katsuyuki Hotta, Naoyuki Nogami et al. · Journal of Thoracic Oncology · 2015 · 103 citations

First-line Therapy, Phase Ii Trial, Medicine +8

Single-Cell Analyses Reveal Diverse Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer

Yukie Kashima, Daisuke Shibahara, Ayako Suzuki et al. · Cancer Research · 2021 · 102 citations · Full text

Microbial Community Structure, Pigment Composition, and Nitrogen Source of Red Snow in Antarctica

Masanori Fujii, Yoshinori Takano, Hisaya Kojima et al. · Microbial Ecology · 2009 · 89 citations · Full text

Engineering, Cyanobacteria, Red Snow Samples +17

Combination treatment with a PI3K/Akt/mTOR pathway inhibitor overcomes resistance to anti-HER2 therapy in PIK3CA-mutant HER2-positive breast cancer cells

Yumi Fujimoto, Tomoko Morita, Akihiro Ohashi et al. · Scientific Reports · 2020 · 85 citations · Full text

Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure

Takayoshi Tsutamoto, Atsuyuki Wada, Keiko Maeda et al. · Journal of the American College of Cardiology · 2000 · 83 citations

Heart Failure, Transcardiac Extraction, Structural Heart Disease +8